EUVIMEDEUVIMED entdecken
Crossref

Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy

Yansong Tang, Mengying Feng, Yang Su, Teng Ma, Hongjie Zhang, Hongchun Wu, Xiaoyu Wang, Shuyue Shi, Ying Zhang, Yawei Xu, Shijun Hu iD, Ke Wei iD und 1 weitere

Circulation · 30.05.2023 · 147 (22) · 1684-1704

DOI: 10.1161/circulationaha.123.064121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 30.05.2023. Verfasst von Yansong Tang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China (Y.T., Y.S., T.M., Y.X., D.X.). Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Heart Failure. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A large portion of idiopathic and familial dilated cardiomyopathy (DCM) cases have no obvious causal genetic variant. Although altered response to metabolic stress has been implicated, the molecular mechanisms underlying the pathogenesis of DCM remain elusive. The JMJD family proteins, initially identified as histone deacetylases, have been shown to be involved in many cardiovascular diseases. Despite their increasingly diverse functions, whether JMJD family members play a role in DCM remains unclear.

Methods

We examined Jmjd4 expression in patients with DCM, and conditionally deleted and overexpressed Jmjd4 in cardiomyocytes in vivo to investigate its role in DCM. RNA sequencing, metabolites profiling, and mass spectrometry were used to dissect the molecular mechanism of Jmjd4-regulating cardiac metabolism and hypertrophy.

Results

We found that expression of Jmjd4 is significantly decreased in hearts of patients with DCM. Induced cardiomyocyte-specific deletion of Jmjd4 led to spontaneous DCM with severely impaired mitochondrial respiration. Pkm2, the less active pyruvate kinase compared with Pkm1, which is normally absent in healthy adult cardiomyocytes but elevated in cardiomyopathy, was found to be drastically accumulated in hearts with Jmjd4 deleted. Jmjd4 was found mechanistically to interact with Hsp70 to mediate degradation of Pkm2 through chaperone-mediated autophagy, which is dependent on hydroxylation of K66 of Pkm2 by Jmjd4. By enhancing the enzymatic activity of the abundant but less active Pkm2, TEPP-46, a Pkm2 agonist, showed a significant therapeutic effect on DCM induced by Jmjd4 deficiency, and heart failure induced by pressure overload, as well.

Conclusions

Our results identified a novel role of Jmjd4 in maintaining metabolic homeostasis in adult cardiomyocytes by degrading Pkm2 and suggest that Jmjd4 and Pkm2 may be therapeutically targeted to treat DCM, and other cardiac diseases with metabolic dysfunction, as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedHeart FailureHumansMyocytes, Cardiac

Stichwörter der Autor:innen

HSP70 heat-shock proteinsJMJD4 protein, mousePkm2 proteincardiomyopathy, dilatedchaperone-mediated autophagyhydroxylationmouse

Autor:innen und Institutionen

  • Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, China (Y.T., Y.S., T.M., Y.X., D.X.).
  • Institute for Regenerative Medicine, Shanghai East Hospital, Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem…
  • Department of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Med…
  • Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, China (X.W.).

ORCID-Profile: Shijun Hu, Ke Wei, Dachun Xu

Zitieren

APA

Tang, Y., Feng, M., Su, Y., Ma, T., Zhang, H., Wu, H., Wang, X., Shi, S., Zhang, Y., Xu, Y., Hu, S., Wei, K., & Xu, D. (2023). Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy. Circulation, 147(22), 1684-1704. https://doi.org/10.1161/circulationaha.123.064121

Vancouver

Tang Y, Feng M, Su Y, Ma T, Zhang H, Wu H, et al. Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy. Circulation. 2023;147(22):1684-1704. doi:10.1161/circulationaha.123.064121

BibTeX
@article{Tang2023,
  author = {Tang, Yansong and Feng, Mengying and Su, Yang and Ma, Teng and Zhang, Hongjie and Wu, Hongchun and Wang, Xiaoyu and Shi, Shuyue and Zhang, Ying and Xu, Yawei and Hu, Shijun and Wei, Ke and Xu, Dachun},
  title = {Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy},
  journal = {Circulation},
  year = {2023},
  volume = {147},
  number = {22},
  pages = {1684--1704},
  doi = {10.1161/circulationaha.123.064121}
}
Kostenlos starten →